col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


51 Results       Page 1

 [1] 
Springer-Verlag: GeroScience
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―11 Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary Noemi Kiss-Dala, Balint Gergely Szabo, Botond Lakatos, Marienn Reti, Janos Szlavik, Istvan Valyi-Nagy
2 [GO] 2022―Oct―03 Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years Marta Del Pozo-Valero, Marta Corton, Rosario López-Rodríguez, Ignacio Mahillo-Fernández, Javier Ruiz-Hornillos, Pablo Minguez, et al. (+66)
3 [GO] 2022―Sep―16 The majority of severe COVID-19 patients develop anti-cardiac autoantibodies Miklós Fagyas, Béla Nagy, Arnold Péter Ráduly, Ivetta Siket Mányiné, Lilla Mártha, Gábor Erdősi, et al. (+13)
4 [GO] 2022―Jul―22 Different patterns of excess all-cause mortality by age and sex in Hungary during the 2nd and 3rd waves of the COVID-19 pandemic Vince Fazekas-Pongor, Zsófia Szarvas, Norbert D. Nagy, Anna Péterfi, Zoltán Ungvári, Viktor J. Horváth, et al. (+2)
5 [GO] 2022―Jul―13 Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, Sang-Soo Lee
6 [GO] 2022―Jun―23 SARS-CoV-2 infection in HIV-infected patients: potential role in the high mutational load of the Omicron variant emerging in South Africa Katalin Réka Tarcsai, Oliga Corolciuc, Attila Tordai, József Ongrádi
7 [GO] 2022―May―11 Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients Ayush Batra, Jeffrey R. Clark, Anthony K. Kang, Sareen Ali, Tulsi R. Patel, Nathan A. Shlobin, et al. (+11)
8 [GO] 2022―May―11 Favipiravir for the treatment of COVID-19 in elderly patients-what do we know after 2 years of COVID-19? Henrietta Papp, Zsófia Lanszki, György M. Keserű, Ferenc Jakab
9 [GO] 2022―Apr―25 Stringent public health measures during COVID-19 across ischemic stroke care systems: the potential impact of patient perceptions on health care-seeking behaviors Calin I. Prodan, Ayush Batra, Zoltan Ungvari, Eric M. Liotta
10 [GO] 2022―Apr―08 Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds Maxence Meyer, Florentin Constancias, Claudia Worth, Anita Meyer, Marion Muller, Alexandre Boussuge, et al. (+7)
11 [GO] 2022―Mar―08 Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, Govindasamy Agoramoorthy, Chiranjib Chakraborty
12 [GO] 2022―Feb―14 SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients Jorge Quarleri, M. Victoria Delpino
13 [GO] 2022―Feb―11 A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor László Dézsi, Tamás Mészáros, Gergely Kozma, Mária H-Velkei, Csaba Zs. Oláh, Miklós Szabó, et al. (+8)
14 [GO] 2022―Jan―07 Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia Coralie Sullerot, Kevin Bouiller, Caroline Laborde, Marine Gilis, Amélie Fèvre, Arthur Hacquin, et al. (+8)
15 [GO] 2022―Jan―05 Modeling of nursing care-associated airborne transmission of SARS-CoV-2 in a real-world hospital setting Attila Nagy, Alpár Horváth, Árpád Farkas, Péter Füri, Tamás Erdélyi, Balázs G. Madas, et al. (+5)
16 [GO] 2021―Dec―21 Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans Veronica Galvan, Jorge Quarleri
17 [GO] 2021―Dec―18 Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load Jorge Quarleri, Veronica Galvan, M. Victoria Delpino
18 [GO] 2021―Nov―05 The elderly at risk: aldosterone as modulator of the immune response to SARS-CoV-2 infection Pasquale Campana, Maria Emiliana Palaia, Maddalena Conte, Teresa Cante, Laura Petraglia, Grazia Daniela Femminella, et al. (+2)
19 [GO] 2021―Oct―21 Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients Miklós Fagyas, Viktor Bánhegyi, Katalin Úri, Attila Enyedi, Erzsébet Lizanecz, Ivetta Siket Mányiné, et al. (+18)
20 [GO] 2021―Oct―11 Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans István Vályi-Nagy, Zsolt Matula, Márton Gönczi, Szabolcs Tasnády, Gabriella Bekő, Marienn Réti, et al. (+2)
21 [GO] 2021―Sep―12 A COVID-19-association-dependent categorization of death causes in 100 autopsy cases Krisztina Danics, Adrián Pesti, Klára Törő, Noémi Kiss-Dala, János Szlávik, Botond Lakatos, et al. (+10)
22 [GO] 2021―Sep―03 Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary Balint Gergely Szabo, Katalin Szidonia Lenart, Borisz Petrik, Zsofia Gaspar, Noemi Kiss-Dala, Janos Szlavik, et al. (+2)
23 [GO] 2021―Sep―01 Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics Jonas Schmidt, Sandro Berghaus, Frithjof Blessing, Folker Wenzel, Holger Herbeck, Josef Blessing, et al. (+3)
24 [GO] 2021―Aug―30 Animal reservoirs of SARS-CoV-2: calculable COVID-19 risk for older adults from animal to human transmission Teresa G. Valencak, Anna Csiszar, Gabor Szalai, Andrej Podlutsky, Stefano Tarantini, Vince Fazekas-Pongor, et al. (+2)
25 [GO] 2021―Aug―18 Impact of COVID-19 on ischemic stroke care in Hungary Péter Pál Böjti, Géza Szilágyi, Balázs Dobi, Rita Stang, István Szikora, Balázs Kis, et al. (+6)
26 [GO] 2021―Jul―17 Therapeutic prevention of COVID-19 in elderly: a case-control study Frederic Blanc, Cedric Waechter, Thomas Vogel, Benoit Schorr, Catherine Demuynck, Catherine Martin Hunyadi, et al. (+16)
27 [GO] 2021―Jul―14 The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification Alberto Cereda, Marco Toselli, Anna Palmisano, Davide Vignale, Riccardo Leone, Valeria Nicoletti, et al. (+29)
28 [GO] 2021―Jun―09 Increased procoagulant platelet levels are predictive of death in COVID-19 Mohamad H. Khattab, Calin I. Prodan, Andrea S. Vincent, Chao Xu, Kellie R. Jones, Sharanjeet Thind, et al. (+6)
29 [GO] 2021―May―21 Acute-care hospital reencounters in COVID-19 patients Jeffrey R. Clark, Ayush Batra, Nathan A. Shlobin, Steven C. Hoffman, Zachary S. Orban, Igor J. Koralnik, Eric M. Liotta
30 [GO] 2021―Apr―10 Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 Registry Florian Huemer, Gabriel Rinnerthaler, Benedikt Jörg, Patrick Morre, Birgit Stegbuchner, Elisabeth Proksch, et al. (+5)
31 [GO] 2021―Feb―11 The impact of immuno-aging on SARS-CoV-2 vaccine development Jennifer Connors, Matthew R. Bell, Jennifer Marcy, Michele Kutzler, Elias K. Haddad
32 [GO] 2021―Jan―20 Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19 Miklós Fagyas, Attila Kertész, Ivetta Mányiné Siket, Viktor Bánhegyi, Bertalan Kracskó, Andrea Szegedi, et al. (+10)
33 [GO] 2021―Jan―18 Age-associated difference in circulating ACE2, the gateway for SARS-COV-2, in humans: results from the InCHIANTI study Majd AlGhatrif, Toshiko Tanaka, Ann Zenobia Moore, Stefania Bandinelli, Edward G. Lakatta, Luigi Ferrucci
34 [GO] 2020―Nov―11 Comparison of clinical characteristics of patients with pandemic SARS-CoV-2-related and community-acquired pneumonias in Hungary - a pilot historical case-control study Viktor J. Horváth, Noémi Hajdú, Orsolya Vági, Karolina Schnábel, Emese Szelke, Anna E. Körei, et al. (+8)
35 [GO] 2020―Oct―01 Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss Richard Kirwan, Deaglan McCullough, Tom Butler, Fatima Perez de Heredia, Ian G. Davies, Claire Stewart
36 [GO] 2020―Sep―08 Correction to: Reflections on designing population surveys for COVID-19 infection and prevalence Akshay Swaminathan, S. V. Subramanian
37 [GO] 2020―Aug―18 Reflections on designing population surveys for COVID-19 infection and prevalence Akshay Swaminathan, S. V. Subramanian
38 [GO] 2020―Aug―07 Companion animals likely do not spread COVID-19 but may get infected themselves Anna Csiszar, Ferenc Jakab, Teresa G. Valencak, Zsófia Lanszki, Gábor Endre Tóth, Gábor Kemenesi, et al. (+3)
39 [GO] 2020―Jul―31 An evaluation of the SARS-CoV-2 epidemic 16 days after the end of social confinement in Hungary Veronica Galvan, Jorge Quarleri
40 [GO] 2020―Jul―27 Learning from success: how has Hungary responded to the COVID pandemic? Martin McKee
41 [GO] 2020―Jul―24 New view on older adults with COVID-19: comments on “SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes” Gang Xu, Min Ye, Jun Zhao, Feng Liu, Wei Ma
42 [GO] 2020―Jul―17 Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary Béla Merkely, Attila J. Szabó, Annamária Kosztin, Ervin Berényi, Andor Sebestyén, Csaba Lengyel, et al. (+17)
43 [GO] 2020―Jun―24 Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity Francesco Nicoli, Maria Teresa Solis-Soto, Deepak Paudel, Peggy Marconi, Riccardo Gavioli, Victor Appay, Antonella Caputo
44 [GO] 2020―Jun―23 Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition Leonardo Bencivenga, Giuseppe Rengo, Gilda Varricchi
45 [GO] 2020―Jun―17 Severe COVID-19 and aging: are monocytes the key? Brandt D. Pence
46 [GO] 2020―Jun―11 The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis Zoltán Vokó, János György Pitter
47 [GO] 2020―May―25 Does SARS-CoV-2 infection cause chronic neurological complications? Erin R. Hascup, Kevin N. Hascup
48 [GO] 2020―May―20 COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches F. Moccia, A. Gerbino, V. Lionetti, M. Miragoli, L. M. Munaron, P. Pagliaro, et al. (+5)
49 [GO] 2020―May―18 Nursing homes and the elderly regarding the COVID-19 pandemic: situation report from Hungary Gábor Kemenesi, László Kornya, Gábor Endre Tóth, Kornélia Kurucz, Safia Zeghbib, Balázs A. Somogyi, et al. (+4)
50 [GO] 2020―May―03 Correction to: SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes Janko Nikolich-Zugich, Kenneth S. Knox, Carlos Tafich Rios, Bhupinder Natt, Deepta Bhattacharya, Mindy J. Fain
51 [GO] 2020―Apr―10 SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes Janko Nikolich-Zugich, Kenneth S. Knox, Carlos Tafich Rios, Bhupinder Natt, Deepta Bhattacharya, Mindy J. Fain
 [1] 

51 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.019 sec